Indications
Anarozh is indicated for treatment of breast cancer in post-menopausal woman with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer.
Indications
Aromrozh tablets are indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following Tamoxifen therapy.
Presentation
Each box contains 100 tablets of 25mg
Indications
Clenrozh is indicated for the treatment of bronchitis in the management of airway obstruction, such as chronic obstructive pulmonary disease (COPD).
Presentation
Each box contains 100 tablets of 40mcg
Indications
Halorozh is indicated for replacement therapy in conditions associated with deficiency or absence of endogenous testosterone such as primary hypogonadism, testicular failure, delayed puberty or metastatic mammary cancer in females.
Indications
Letrozh is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer
Presentation
Each box contains 100 tablets of 2.5mg
Indications
Liorozh is indicated for replacement therapy in hypothyroidism patients, treatment of thyroid nodules, multinodular goiters and enlargement in chronic thyroiditis.
Presentation
Each box contains 100 tablets of 25mcg
